126 related articles for article (PubMed ID: 31028803)
1. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein.
Wang Y; Mao Y; Zhang X; Liu H; Peng W; Liang L; Shi M; Xiao Y; Zhang Y; Zhang F; Yan R; Guo B
Life Sci; 2019 Jul; 228():1-10. PubMed ID: 31028803
[TBL] [Abstract][Full Text] [Related]
2. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
3. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
[TBL] [Abstract][Full Text] [Related]
4. SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.
Liu L; Shi M; Wang Y; Zhang C; Su B; Xiao Y; Guo B
PLoS One; 2017; 12(3):e0174471. PubMed ID: 28350874
[TBL] [Abstract][Full Text] [Related]
5. Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.
Liu L; Wang Y; Yan R; Li S; Shi M; Xiao Y; Guo B
PLoS One; 2016; 11(3):e0151986. PubMed ID: 27010330
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
Xu H; Sun F; Li X; Sun L
Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
[TBL] [Abstract][Full Text] [Related]
7. BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions.
Wang Y; Xiao Y; Li S; Shi L; Liu L; Zhang Y; Shi M; Guo B
Mol Med Rep; 2017 Sep; 16(3):3308-3314. PubMed ID: 28765970
[TBL] [Abstract][Full Text] [Related]
8. BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease.
Peng W; Zhou X; Xu T; Mao Y; Zhang X; Liu H; Liang L; Liu L; Liu L; Xiao Y; Zhang F; Li S; Shi M; Zhou Y; Tang L; Wang Y; Guo B
Cell Death Dis; 2022 Mar; 13(3):254. PubMed ID: 35314669
[TBL] [Abstract][Full Text] [Related]
9. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
10. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
Ai K; Zhu X; Kang Y; Li H; Zhang L
Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
[TBL] [Abstract][Full Text] [Related]
11. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
12. [Regulatory effect of berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy].
Liu S; Yu N; Zhang XL; Chen XQ; Tang LQ
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3604-10. PubMed ID: 23477149
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of smurf2 in regulating the expression of SnoN in diabetic nephropathy.
Xu Z; Diao Z; Liu R; Liu W
Mol Med Rep; 2017 May; 15(5):2560-2566. PubMed ID: 28447757
[TBL] [Abstract][Full Text] [Related]
14. SnoN as a key regulator of the high glucose-induced epithelial-mesenchymal transition in cells of the proximal tubule.
Liu R; Wang Y; Xiao Y; Shi M; Zhang G; Guo B
Kidney Blood Press Res; 2012; 35(6):517-28. PubMed ID: 22813962
[TBL] [Abstract][Full Text] [Related]
15. Blood glucose control contributes to protein stability of Ski-related novel protein N in a rat model of diabetes.
Liang L; Li S; Liu H; Mao Y; Liu L; Zhang X; Peng W; Xiao Y; Zhang F; Shi M; Wang Y; Guo B
Exp Ther Med; 2021 Nov; 22(5):1341. PubMed ID: 34630695
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.
Huang W; Yang C; Nan Q; Gao C; Feng H; Gou F; Chen G; Zhang Z; Yan P; Peng J; Xu Y
Biomed Res Int; 2014; 2014():684765. PubMed ID: 25003128
[TBL] [Abstract][Full Text] [Related]
19. TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation.
Kajino T; Omori E; Ishii S; Matsumoto K; Ninomiya-Tsuji J
J Biol Chem; 2007 Mar; 282(13):9475-9481. PubMed ID: 17276978
[TBL] [Abstract][Full Text] [Related]
20. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
Lang H; Dai C
Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
